|
Update on tuberculosis - 2005
March 01, 2006A reduction in tuberculosis (TB) incidence, prevalence and death rate can be achieved by 2015 in most parts of the world, with the greatest challenges occurring in Africa and Eastern Europe, according to a projection by the Stop TB Department of the World Health Organization.
This assessment appears in the first issue for March 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
Tuberculosis is a contagious, potentially fatal infection primarily caused by the airborne bacterium Mycobacterium tuberculosis. Factors that contribute to the spread of TB, particularly in developing nations, include: overcrowding and unsanitary living conditions in urban areas, homeless shelters and prisons; the emergence of multi-drug resistant disease strains; and the spread of HIV and AIDS, which weaken the human immune system and make infection more likely.
Wing Wai Yew, M.B., of the Tuberculosis and Chest Unit at Grantham Hospital in Hong Kong, China, and a colleague examine the worldwide state of TB epidemiology, diagnosis and treatment as shown through research results published during 2005.
"In sub-Saharan Africa, tuberculosis remains the top cause of HIV-related mortality," said Dr. Yew. "The incidence of tuberculosis in adults receiving highly active anti-retroviral therapy is lower than in untreated HIV-infected adults, but still higher than among HIV-negative adults."
Another study cited by the authors highlights the importance of recent infection with M. tuberculosis in an area with high HIV prevalence, as shown by the situation in northern Malawi in Africa. "The proportion of (TB) strains found to be clustered [here] was among the highest in the world," noted the report.
In a study of South African gold miners, TB incidence doubled within the first year of HIV infection.
For detection of possible TB infection, the U.S. Food and Drug Administration has approved a new interferon-gamma blood test. It is currently evaluating the enzyme-linked immunospot (ELISPOT) assay, which has already been approved in Europe.
"The ELISPOT appears to be at least as sensitive as the tuberculin skin test (TST) for diagnosis of latent tuberculosis infection in contacts of patients with tuberculosis and is likely to be more specific than the TST in bacilli Calmette-Guérin (BCG) vaccine," said Dr. Yew.
(The BCG vaccine, which is not 100 percent effective, is used most often in developing countries.)
The most common antibiotics used to treat TB are isoniazid, rifampin, pyrazinamide, streptomycin and ethambutol. "Rifampin has a well-documented interaction with some highly active antiretroviral agents, especially HIV protease inhibitors," said Dr. Yew.
He noted that an alternate member of the rifamycin class called rifabutin has much less effect against the antiretroviral agents. "Thus, rifabutin-based therapy appears to be a better choice for HIV tuberculosis," he added.
However, another research study showed that rifabutin therapy for advanced HIV-related tuberculosis, while well-tolerated, could be associated with a high risk for either failure or relapse in the presence of significant immunosuppressive therapy.
In other research, a group of investigators concluded that lower plasma concentrations of rifabutin, and perhaps isoniazid, were associated with relapse in TB patients with HIV who received only twice-weekly antituberculosis therapy.
Finally, in animal studies, moxifloxacin, a drug with a long half-life that has potent bactericidal and sterilizing powers, has produced a stable cure, without relapse, in a mouse model of tuberculosis.
American Thoracic Society
Wing Wai Yew, M.B., of the Tuberculosis and Chest Unit at Grantham Hospital in Hong Kong, China, and a colleague examine the worldwide state of TB epidemiology, diagnosis and treatment as shown through research results published during 2005.
"In sub-Saharan Africa, tuberculosis remains the top cause of HIV-related mortality," said Dr. Yew. "The incidence of tuberculosis in adults receiving highly active anti-retroviral therapy is lower than in untreated HIV-infected adults, but still higher than among HIV-negative adults."
Another study cited by the authors highlights the importance of recent infection with M. tuberculosis in an area with high HIV prevalence, as shown by the situation in northern Malawi in Africa. "The proportion of (TB) strains found to be clustered [here] was among the highest in the world," noted the report.
In a study of South African gold miners, TB incidence doubled within the first year of HIV infection.
For detection of possible TB infection, the U.S. Food and Drug Administration has approved a new interferon-gamma blood test. It is currently evaluating the enzyme-linked immunospot (ELISPOT) assay, which has already been approved in Europe.
"The ELISPOT appears to be at least as sensitive as the tuberculin skin test (TST) for diagnosis of latent tuberculosis infection in contacts of patients with tuberculosis and is likely to be more specific than the TST in bacilli Calmette-Guérin (BCG) vaccine," said Dr. Yew.
(The BCG vaccine, which is not 100 percent effective, is used most often in developing countries.)
The most common antibiotics used to treat TB are isoniazid, rifampin, pyrazinamide, streptomycin and ethambutol. "Rifampin has a well-documented interaction with some highly active antiretroviral agents, especially HIV protease inhibitors," said Dr. Yew.
He noted that an alternate member of the rifamycin class called rifabutin has much less effect against the antiretroviral agents. "Thus, rifabutin-based therapy appears to be a better choice for HIV tuberculosis," he added.
However, another research study showed that rifabutin therapy for advanced HIV-related tuberculosis, while well-tolerated, could be associated with a high risk for either failure or relapse in the presence of significant immunosuppressive therapy.
In other research, a group of investigators concluded that lower plasma concentrations of rifabutin, and perhaps isoniazid, were associated with relapse in TB patients with HIV who received only twice-weekly antituberculosis therapy.
Finally, in animal studies, moxifloxacin, a drug with a long half-life that has potent bactericidal and sterilizing powers, has produced a stable cure, without relapse, in a mouse model of tuberculosis.
American Thoracic Society
Tuberculosis News and Current Tuberculosis Events RSSStudy helps identify which populations of foreign-born persons living in US at higher risk of TB
The relative yield of finding and treating latent tuberculosis is particularly high among higher-risk groups of foreign-born persons living in the U.S., such as individuals from most countries of sub-Saharan Africa and Southeast Asia.
Tuberculosis presents major challenges to HIV treatment in developing countries
Human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings must aggressively address tuberculosis (TB) and the emerging multidrug-resistant TB epidemic to save patient lives and to curb the global TB burden, a major cause of death for persons with HIV.
Bovine tuberculosis in wildlife threatens endangered lynx and cattle health
In an epidemiological survey of Spain's Doņana National Park, the findings of which are published on July 23 in the journal PLoS ONE, Christian Gortázar and colleagues studied the prevalence of bovine tuberculosis (bovine TB) infection among populations of wild boar, red deer and fallow deer in the national park, which is located in southern Spain.
New Guidelines for Treating Rheumatoid Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).
Malaria Millennium Development Goal 'unlikely to be met'
The Millennium Development Goal (MDG) to halt and begin to reverse the incidence of malaria globally is unlikely to be met, according to Wellcome Trust Principal Research Fellow Professor Bob Snow.
New indicator uncovered that can predict coral health
A new indicator of coral health has been discovered in a community of microscopic single-celled algae called dinoflagellates.
D-cycloserine may improve behavioral therapy treatment for anxiety
Anxiety is a normal human response to stress, but in some, it can develop into a disabling disorder of excessive and irrational fears, such as obsessive-compulsive disorder, panic disorder, or posttraumatic stress disorder. Effective treatments are available and can involve either behavioral therapy or medications.
New Electrostatic-based DNA Microarray Technique Could Revolutionize Medical Diagnostics
The dream of personalized medicine - in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile - may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics.
Predicting TB outbreaks based on the first 2 cases
Outbreaks of tuberculosis (TB) may be able to be identified by looking at certain characteristics of the first two patients, according to new research.
Radical reform is needed to stop the 'inhumane' practice of transplant tourism
The UK government must bring in presumed consent to organ donation or allow a controlled donor compensation programme for unrelated live donors, in order to bring the "inhumane" practice of transplant tourism from the UK to an end, claims a doctor in this week's BMJ.
More Tuberculosis News Articles
 | The Air We Breathe: A Novel by Andrea Barrett |
 | Illness as Metaphor and AIDS and Its Metaphors by Susan Sontag |
 | Joe Gans: A Biography of the First African American World Boxing Champion by Colleen Aycock, Mark Scott |
 | Identification Problems in the Social Sciences by Charles F. Manski |
 | Basic Infection Control for Healthcare Providers by Michael Kennamer |
 | Towns of the Sandia Mountains (NM) (Images of America) by Mike Smith |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | The White Death: A History of Tuberculosis by Thomas Dormandy |
| 13 is too young to die by Isaacsen-Bright | |
 | WINGS OF THE DOVE, THE - KINDLE EDITION [ENG] by Henry James |
| © 2008 BrightSurf.com |